1
|
Zhang S, Deliyore-Ramírez J, Deng S, Nair B, Pesquera D, Jing Q, Vickers ME, Crossley S, Ghidini M, Guzmán-Verri GG, Moya X, Mathur ND. Highly reversible extrinsic electrocaloric effects over a wide temperature range in epitaxially strained SrTiO 3 films. Nat Mater 2024; 23:639-647. [PMID: 38514844 PMCID: PMC11068575 DOI: 10.1038/s41563-024-01831-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Accepted: 02/06/2024] [Indexed: 03/23/2024]
Abstract
Electrocaloric effects have been experimentally studied in ferroelectrics and incipient ferroelectrics, but not incipient ferroelectrics driven ferroelectric using strain. Here we use optimally oriented interdigitated surface electrodes to investigate extrinsic electrocaloric effects in low-loss epitaxial SrTiO3 films near the broad second-order 243 K ferroelectric phase transition created by biaxial in-plane coherent tensile strain from DyScO3 substrates. Our extrinsic electrocaloric effects are an order of magnitude larger than the corresponding effects in bulk SrTiO3 over a wide range of temperatures including room temperature, and unlike electrocaloric effects associated with first-order transitions they are highly reversible in unipolar applied fields. Additionally, the canonical Landau description for strained SrTiO3 films works well if we set the low-temperature zero-field polarization along one of the in-plane pseudocubic <100> directions. In future, similar strain engineering could be exploited for other films, multilayers and bulk samples to increase the range of electrocaloric materials for energy efficient cooling.
Collapse
Affiliation(s)
- S Zhang
- College of Science, National University of Defense Technology, Changsha, China.
- Department of Materials Science, University of Cambridge, Cambridge, UK.
| | - J Deliyore-Ramírez
- Centro de Investigación en Ciencia e Ingeniería de Materiales (CICIMA), Universidad de Costa Rica, San José, Costa Rica
- Escuela de Física, Universidad de Costa Rica, San José, Costa Rica
| | - S Deng
- Beijing Advanced Innovation Center for Materials Genome Engineering, University of Science and Technology Beijing, Beijing, China
| | - B Nair
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - D Pesquera
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - Q Jing
- Department of Materials Science, University of Cambridge, Cambridge, UK
- James Watt School of Engineering, University of Glasgow, Glasgow, UK
| | - M E Vickers
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - S Crossley
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - M Ghidini
- Department of Materials Science, University of Cambridge, Cambridge, UK
- DiFeST, University of Parma, Parma, Italy
- Diamond Light Source, Chilton, Didcot, UK
| | - G G Guzmán-Verri
- Department of Materials Science, University of Cambridge, Cambridge, UK.
- Centro de Investigación en Ciencia e Ingeniería de Materiales (CICIMA), Universidad de Costa Rica, San José, Costa Rica.
- Escuela de Física, Universidad de Costa Rica, San José, Costa Rica.
| | - X Moya
- Department of Materials Science, University of Cambridge, Cambridge, UK.
| | - N D Mathur
- Department of Materials Science, University of Cambridge, Cambridge, UK.
| |
Collapse
|
2
|
Buccino F, Cervellera F, Ghidini M, Marini R, Bagherifard S, Vergani LM. Isolating the Role of Bone Lacunar Morphology on Static and Fatigue Fracture Progression through Numerical Simulations. Materials (Basel) 2023; 16:1931. [PMID: 36903046 PMCID: PMC10004234 DOI: 10.3390/ma16051931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/05/2023] [Revised: 02/13/2023] [Accepted: 02/23/2023] [Indexed: 06/18/2023]
Abstract
Currently, the onset of bone damage and the interaction of cracks with the surrounding micro-architecture are still black boxes. With the motivation to address this issue, our research targets isolating lacunar morphological and densitometric effects on crack advancement under both static and cyclic loading conditions by implementing static extended finite element models (XFEM) and fatigue analyses. The effect of lacunar pathological alterations on damage initiation and progression is evaluated; the results indicate that high lacunar density considerably reduces the mechanical strength of the specimens, resulting as the most influencing parameter among the studied ones. Lacunar size has a lower effect on mechanical strength, reducing it by 2%. Additionally, specific lacunar alignments play a key role in deviating the crack path, eventually slowing its progression. This could shed some light on evaluating the effects of lacunar alterations on fracture evolution in the presence of pathologies.
Collapse
|
3
|
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C. Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey. ESMO Open 2023; 8:100777. [PMID: 36731325 PMCID: PMC10024128 DOI: 10.1016/j.esmoop.2022.100777] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 12/04/2022] [Accepted: 12/19/2022] [Indexed: 02/03/2023] Open
Abstract
BACKGROUND Information about the adherence to scientific societies guidelines in the 'real-world' therapeutic management of oncological patients are lacking. This multicenter, prospective survey was aimed to improve the knowledge relative to 2017-2018 recommendations of the Italian Association of Medical Oncology (AIOM). PATIENTS AND METHODS Treatment-naive adult patients with pancreatic adenocarcinoma were enrolled. Group A received adjuvant therapy, group B received primary chemotherapy, and group C had metastatic disease. The results on patients accrued until 31 October 2019 with a mature follow-up were presented. RESULTS Since July 2017, 833 eligible patients of 923 (90%) were enrolled in 44 Italian centers. The median age was 69 years (range 36-89 years; 24% >75 years); 48% were female; 93% had Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0 or 1; group A: 16%, group B: 30%; group C: 54%; 72% Nord, 13% Center, 15% South. In group A, guidelines adherence was 68% [95% confidence interval (CI) 59% to 76%]; 53% of patients received gemcitabine and 15% gemcitabine + capecitabine; median CA19.9 was 29 (range 0-7300; not reported 15%); median survival was 36.4 months (95% CI 27.5-47.3 months). In group B, guidelines adherence was 96% (95% CI 92% to 98%); 55% of patients received nab-paclitaxel + gemcitabine, 27% FOLFIRINOX, 12% gemcitabine, and 3% clinical trial; median CA19.9 was 337 (range 0-20220; not reported 9%); median survival was 18.1 months (95% CI 15.6-19.9 months). In group C, guidelines adherence was 96% (95% CI 94% to 98%); 71% of patients received nab-paclitaxel + gemcitabine, 16% gemcitabine, 8% FOLFIRINOX, and 4% clinical trial; liver and lung metastases were reported in 76% and 23% of patients, respectively; median CA19.9 value was 760 (range 0-1374500; not reported 9%); median survival was 10.0 months (95% CI 9.1-11.1 months). CONCLUSIONS The GARIBALDI survey shows a very high rate of adherence to guidelines and survival outcome in line with the literature. CA19.9 testing should be enhanced; nutritional and psychological counseling represent an unmet need. Enrollment to assess adherence to updated AIOM guidelines is ongoing.
Collapse
Affiliation(s)
- M Reni
- Department of Medical Oncology, Vita e Salute University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
| | - E Giommoni
- Medical Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - F Bergamo
- Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy
| | - M Milella
- Oncology Verona, Policlinico Universitario G.B. Rossi Borgo Roma, Verona, Italy
| | - L Cavanna
- Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy
| | | | - M Spada
- Unit of Oncology, San Raffaele G. Giglio Institute, Contrada Pietrapollastra - Pisciotto, Cefalù, Italy
| | - S Cordio
- ARNAS Garibaldi Nesima - Catania, Italy
| | - G Aprile
- San Bortolo General Hospital, ULSS8 Berica Est District - Vicenza, Italy
| | - G G Cardellino
- Department of Oncology, University & General Hospital, Udine Pz.le S. Maria della Misericordia 15, Udine, Italy
| | - E Maiello
- Medical Oncology, Hospital Casa Sollievo Della Sofferenza-San Giovanni Rotondo, Foggia, Italy
| | - I Bernardini
- Department of Oncology, Carpi and Mirandola Hospitals, Carpi e Mirandola, Italy
| | | | - S Bozzarelli
- Clinical Institute Humanitas - Rozzano (Milan), Milan, Italy
| | - M Macchini
- Department of Medical Oncology, Vita e Salute University, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - G Orsi
- Department of Medical Oncology, Vita e Salute University, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - I De Simone
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - Er Rulli
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - L Porcu
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - V Torri
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - C Pinto
- AUSL-IRCCS Clinical Cancer Center of Reggio Emilia - Reggio Emilia, Italy
| | | |
Collapse
|
4
|
Tomasello G, Gambini D, Petrelli F, Azzollini J, Arcanà C, Ghidini M, Peissel B, Manoukian S, Garrone O. Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis. ESMO Open 2022; 7:100531. [PMID: 35810556 PMCID: PMC9463372 DOI: 10.1016/j.esmoop.2022.100531] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 05/28/2022] [Accepted: 05/31/2022] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Pathogenic variants (PVs) in BRCA1/2 genes account for ∼6% of breast and 20% of ovarian cancers. Most breast tumors developed by BRCA1 carriers are triple negative. BRCA2 tumors have similar rates of estrogen receptor positivity as sporadic controls but are less likely to be human epidermal growth factor receptor 2 (HER2)-positive. Prevalence of HER2 positivity among breast cancers (BCs) in BRCA1/2 mutation carriers is poorly and variably described, ranging from 0% to 10% and 0% to 13% in BRCA1 and BRCA2 carriers, respectively. PATIENTS AND METHODS We assessed the prevalence of HER2 positivity among a single institutional cohort of 398 BCs developed in carriers of BRCA1/2 PVs (240 BRCA1, 158 BRCA2). Subsequently, a systematic review of the literature and pooled analysis was carried out. RESULTS In our series we found a 7% HER2 positivity rate among all first BRCA1/2 BCs overall. In BRCA1 carriers, 5.4% of BCs were HER2-positive compared with 9.5% in BRCA2-mutated patients. Among bilateral BCs, HER2-positive cases were 15.2% in the BRCA1 group and 23.1% in the BRCA2 group. Notably, six BRCA1 and eight BRCA2 carriers showed discordant HER2 status between BC and bilateral BC (23.7%, 14/59). The systematic review included 21 083 BRCA1/2 patients from 73 eligible studies. The pooled rate of BRCAmut/HER2-positive BCs is 9.1% (95% confidence interval 7.3% to 11.2%). BRCA1 and BRCA2 when reported as separate data ranged from 0% to 33.3% (mean 8.3%) and from 0% to 86% (mean 10.3%), respectively. CONCLUSIONS As compared with sporadic cases, BCs occurring in BRCA1 and/or BRCA2 PVs carriers are less frequently HER2-positive. Prevalence of HER2 positivity in our series was consistent with pooled analysis and did not exceed 10%. Although not common, co-existence of BRCA mutations and HER2 overexpression and/or gene amplification should be acknowledged. More research is needed to better characterize this subgroup of patients who should not be excluded a priori from clinical trials of targeted therapy for BRCA1/2-driven cancers.
Collapse
Affiliation(s)
- G Tomasello
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
| | - D Gambini
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - F Petrelli
- Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy
| | - J Azzollini
- Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - C Arcanà
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M Ghidini
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - B Peissel
- Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - S Manoukian
- Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - O Garrone
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| |
Collapse
|
5
|
Reni M, Bergamo F, Giommoni E, Milella M, Cavanna L, Di Marco M, Artioli F, Silvestris N, Spada M, Ghidini M, Maiello E, Cardellino G, Macchini M, Orsi G, Manai C, Valente M, Torri V, Porcu L, Giugliano V, Beretta G. 1562P Observational prospective study of Italian guidelines application for patients with pancreatic ductal adenocarcinoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
6
|
Indini A, Cattaneo M, Ghidini M, Rijavec E, Bareggi C, Galassi B, Gambini D, Grossi F. 1765P Developing a risk assessment score for cancer patients during the COVID-19 pandemic. Ann Oncol 2020. [PMCID: PMC7506343 DOI: 10.1016/j.annonc.2020.08.1829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
7
|
Grossi F, Cattaneo M, Rijavec E, Ghidini M, Bareggi C, Galassi B, Gambini D, Berti E, Indini A. 1696P Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study. Ann Oncol 2020. [PMCID: PMC7506302 DOI: 10.1016/j.annonc.2020.08.1760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
8
|
Caputo F, Gelsomino F, Spallanzani A, Pettorelli E, Benatti S, Ghidini M, Grizzi G, Ratti M, Merz V, Messina C, Tonelli R, Luppi G, Melisi D, Dominici M, Salati M. 63P Multicentre match-paired analysis of advanced biliary cancer (ABC) long-term survivors: The BILONG study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
9
|
Ghidini M, Indini A, Rijavec E, Bareggi C, Cattaneo M, Galassi B, Gambini D, Grossi F. 1689P The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists. Ann Oncol 2020. [PMCID: PMC7506453 DOI: 10.1016/j.annonc.2020.08.1753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Roberto M, Bianco FL, Arrivi G, Pietro FD, Gariazzo L, Gelsomino F, Ghidini M, Ficorella C, Parisi A, Urbano F, Dell'Aquila E, Mazzuca F. P-348 A multi-institutional retrospective study of stage I-IV transverse colon cancer: Diagnosis, treatment and outcome analyses. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
11
|
Parisi A, Camarda F, Ribelli M, Rossini D, Germani M, Dell'Aquila E, Natoli C, Pietro D, Corsi D, Zurlo I, Lombardi P, Zanaletti N, Giampieri R, Merloni F, Occhipinti M, Marchetti P, Roberto M, Mazzuca F, Ghidini M, Garajová I, Zoratto F, Ficorella C. P-168 Second-line, anti-VEGF based after first-line, anti-EGFR based treatment in RAS wild-type metastatic colorectal cancer: The multicenter, retrospective, real-life SLAVE study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
12
|
Salati M, Marcheselli L, Ruvo ND, Esposito G, Fenocchi S, Cucciarrè G, Serra F, Cautero N, Cabry F, Gelmini R, Vittimberga G, Radi G, Solaini L, Morgagni P, Ercolani G, Ghidini M, Grizzi G, Ratti M, Gelsomino F, Luppi G, Dominici M, Spallanzani A. SO-12 Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
13
|
Kurdi S, Ghidini M, Divitini G, Nair B, Kursumovic A, Tiberto P, Dhesi SS, Barber ZH. Exchange-bias via nanosegregation in novel Fe 2-x Mn 1+x Al ( x = -0.25, 0, 0.25) Heusler films. Nanoscale Adv 2020; 2:2602-2609. [PMID: 36133395 PMCID: PMC9417214 DOI: 10.1039/c9na00689c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Accepted: 04/28/2020] [Indexed: 06/14/2023]
Abstract
Exchange-bias has been reported in bulk nanocrystalline Fe2MnAl, but individual thin films of this Heusler alloy have never been studied so far. Here we study the structural and magnetic properties of nanocrystalline thin films of Fe2-x Mn1+x Al (x = -0.25, 0 and 0.25) obtained by sputtering and ex situ post-deposition annealing. We find that Fe2MnAl films display exchange-bias, and that varying Mn concentration determines the magnitude of the effect, which can be either enhanced (in Fe1.75Mn1.25Al) or suppressed (in Fe2.25Mn0.75Al). X-ray diffraction shows that our films present a mixed L21-B2 Heusler structure where increasing Mn concentration favors the partial transformation of the L21 phase into the B2 phase. Scanning transmission electron microscopy (STEM) and energy dispersive X-ray spectroscopy (EDX) reveal that this composition-driven L21 → B2 transformation is accompanied by phase segregation at the nanoscale. As a result, the Fe2-x Mn1+x Al films that show exchange-bias (x = 0, 0.25) are heterogeneous, with nanograins of an Fe-rich phase embedded in a Mn-rich matrix (a non-negative matrix factorisation algorithm was used to give an indication of the phase composition from EDX data). Our comparative analysis of XRD, magnetometry and X-ray magnetic circular dichroism (XMCD), shows that the Fe-rich nanograins and Mn-rich matrix are composed of a ferromagnetic L21 phase and an antiferromagnetic B2 phase, respectively, thus revealing that exchange-coupling between these two phases is the cause of the exchange-bias effect. Our work should inspire the development of single-layer, environmentally friendly spin valve devices based on nanocomposite Heusler films.
Collapse
Affiliation(s)
- S Kurdi
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| | - M Ghidini
- Department of Physics, Mathematics and Computer Science, University of Parma 43130 Parma Italy
- Diamond Light Source Chilton Didcot OX11 0DE Oxfordshire UK
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| | - G Divitini
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| | - B Nair
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| | - A Kursumovic
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| | - P Tiberto
- The National Institute for Metrological Research (INRIM) 10135 Torino Italy
| | - S S Dhesi
- Diamond Light Source Chilton Didcot OX11 0DE Oxfordshire UK
| | - Z H Barber
- Department of Materials Science and Metallurgy, University of Cambridge CB3 0FS Cambridge UK
| |
Collapse
|
14
|
Ghidini M, Mansell R, Pellicelli R, Pesquera D, Nair B, Moya X, Farokhipoor S, Maccherozzi F, Barnes CHW, Cowburn RP, Dhesi SS, Mathur ND. Voltage-driven annihilation and creation of magnetic vortices in Ni discs. Nanoscale 2020; 12:5652-5657. [PMID: 32101212 DOI: 10.1039/c9nr08672b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Using photoemission electron microscopy (PEEM) to image ferromagnetism in polycrystalline Ni disks, and ferroelectricity in their single-crystal BaTiO3 substrates, we find that voltage-driven 90° ferroelectric domain switching serves to reversibly annihilate each magnetic vortex via uniaxial compressive strain, and that the orientation of the resulting bi-domain reveals the chirality of the annihilated vortex. Micromagnetic simulations reveal that only 60% of this strain is required for annihilation. Voltage control of magnetic vortices is novel, and should be energetically favourable with respect to the use of a magnetic field or an electrical current. In future, stray field from bi-domains could be exploited to read vortex chirality. Given that core polarity can already be read via stray field, our work represents a step towards four-state low-power memory applications.
Collapse
Affiliation(s)
- M Ghidini
- Department of Mathematics, Physics and Computer Science, University of Parma, 43124 Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Alsina M, Tabernero J, Arkenau HT, Squadroni M, Doi T, Faustino C, Ghidini M, Mansoor W, Shitara K, Van Cutsem E, Causse-Amellal N, Leger C, Skanji D, Ilson D. Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
16
|
Ghidini M, Hahne J, Senti C, Lampis A, Ratti M, Pizzo C, Tomasello G, Passalacqua R, Valeri N. Circulating-free DNA analysis from long-term surviving metastatic colorectal cancer patients undergoing surgery for resectable disease. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz268.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
17
|
Hahne J, Lampis A, Ghidini M, Ratti M, Salati M, Senti C, Passalacqua R, Cascione L, Braconi C, Sansom O, Fassan M, Valeri N. Detection of microRNAs as biomarker for anti-EGFR antibody resistance in colon cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz268.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Ghidini M, Mansell R, Maccherozzi F, Moya X, Phillips LC, Yan W, Pesquera D, Barnes CHW, Cowburn RP, Hu JM, Dhesi SS, Mathur ND. Shear-strain-mediated magnetoelectric effects revealed by imaging. Nat Mater 2019; 18:840-845. [PMID: 31110346 DOI: 10.1038/s41563-019-0374-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Accepted: 04/12/2019] [Indexed: 06/09/2023]
Abstract
Large changes in the magnetization of ferromagnetic films can be electrically driven by non-180° ferroelectric domain switching in underlying substrates, but the shear components of the strains that mediate these magnetoelectric effects have not been considered so far. Here we reveal the presence of these shear strains in a polycrystalline film of Ni on a 0.68Pb(Mg1/3Nb2/3)O3-0.32PbTiO3 substrate in the pseudo-cubic (011)pc orientation. Although vibrating sample magnetometry records giant magnetoelectric effects that are consistent with the hitherto expected 90° rotations of a global magnetic easy axis, high-resolution vector maps of magnetization (constructed from photoemission electron microscopy data, with contrast from X-ray magnetic circular dichroism) reveal that the local magnetization typically rotates through smaller angles of 62-84°. This shortfall with respect to 90° is a consequence of the shear strain associated with ferroelectric domain switching. The non-orthogonality represents both a challenge and an opportunity for the development and miniaturization of magnetoelectric devices.
Collapse
Affiliation(s)
- M Ghidini
- Department of Mathematics, Physics and Computer Science, University of Parma, Parma, Italy.
- Diamond Light Source, Didcot, UK.
- Department of Materials Science, University of Cambridge, Cambridge, UK.
| | - R Mansell
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
| | | | - X Moya
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - L C Phillips
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - W Yan
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - D Pesquera
- Department of Materials Science, University of Cambridge, Cambridge, UK
| | - C H W Barnes
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
| | - R P Cowburn
- Cavendish Laboratory, University of Cambridge, Cambridge, UK
| | - J-M Hu
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI, USA
| | | | - N D Mathur
- Department of Materials Science, University of Cambridge, Cambridge, UK.
| |
Collapse
|
19
|
Parisi A, Cortellini A, Roberto M, Venditti O, Santini D, Dell’Aquila E, Stellato M, Marchetti P, Occhipinti M, Zoratto F, Mazzuca F, Tinari N, De Tursi M, Iezzi L, Natoli C, Ratti M, Pizzo C, Ghidini M, Ficorella C, Cannita K. A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Reni M, Bergamo F, Cavanna L, Spada M, Ghidini M, Giommoni E, Maiello E, Artioli F, Cardellino G, Torri V, Cinquini M, Giugliano V, Pinto C. Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Rossini D, Sbrana A, Bergamo F, Manai C, Santini D, Ghidini M, Antoniotti C, Moretto R, Marmorino F, Urbano F, Ronzoni M, Noventa S, Randon G, Carlomagno C, Latiano T, Cordio S, Granetto C, Cremolini C, Falcone A, Antonuzzo A. Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz156.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
22
|
Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Liguigli W, Maglietta G, Pergola L, Ratti M, Sabadini G, Toppo L, Ungari M, Passalacqua R. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer 2019; 19:212. [PMID: 30849945 PMCID: PMC6408835 DOI: 10.1186/s12885-019-5366-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2018] [Accepted: 02/11/2019] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND The gastric cancer incidence rate differs widely across geographical areas. In Italy, in the province of Cremona the incidence is high, compared to the national situation. For this reason a specialized population-based registry was set up. METHODS The collection encompasses all gastric cancers diagnosed in the three districts of the province since January 1, 2010. The main data sources were the pathological and Hospital Discharge Records and patient clinical charts. Only diagnoses of primary gastric cancer were considered. For each case the following variables were registered: personal data, medical history and symptoms at diagnosis; imaging assessments performed, details on surgery and other treatments received; genetic background and biomolecular characteristics; social and environmental factors. RESULTS As of November 2017, 1087 cases were collected; of which 876, diagnosed up to December 2015, were analyzed. Male/female ratio was 1.4. The European Age-standardized Incidence Rate was 41.4 for males and 28.3 for females as compared to a national average of 33.3 and 17.0 respectively. Median age at diagnosis was 73 for male and 78 for female. Helicobacter Pylori infection was present in fewer than 20% of cases. HER-2 gene was amplified in about 25% of cases. Primary tumour location was the gastro-esophageal junction or cardia in 17.5% in males and 8.3% in females. The majority of cases (58.3%) were diagnosed at an advanced stage and overall only 41.2% underwent surgery. Median overall survival was 14.8 months for men and 18.5 for women. Age standardized 5-year relative survival was 31.4% for men and 40.5% for females. Neoadjuvant treatment was performed in fewer than 10% of patients who underwent surgery, and the rate of postoperative therapy adherence was low. DISCUSSION This study shows a high gastric cancer incidence in the province of Cremona, with a geographical spread across different districts. Moreover, a high percentage of gastric cancers were detected at an advanced stage of disease and a low rate of 5-year relative survival was registered. Based on these findings, effective preventive interventional health strategies and screening procedures need to be implemented to reduce the impact of this pathology in this geographical area.
Collapse
Affiliation(s)
- B M Donida
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy.
| | - G Tomasello
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| | - M Ghidini
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| | - F Buffoli
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| | - M Grassi
- ASST of Crema, Largo Ugo Dossena 2, 26013, Crema, CR, Italy
| | - W Liguigli
- Hospital of Suzzara, Via General Cantore 14/b, 46029, Suzzara, MN, Italy
| | - G Maglietta
- University Hospital of Parma, Via Gramsci 14, 43126, Parma, PR, Italy.,University of Florence, 50121, Parma, FI, Italy
| | - L Pergola
- ASST of Crema, Largo Ugo Dossena 2, 26013, Crema, CR, Italy
| | - M Ratti
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| | - G Sabadini
- Istituto Figlie San Camillo of Cremona, Via Fabio Filzi 56, 26100, Cremona, CR, Italy
| | - L Toppo
- Civil Hospital of Voghera, ASST of Pavia, Via Indipendenza 34, 27100, Pavia, PV, Italy
| | - M Ungari
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| | - R Passalacqua
- ASST of Cremona, Viale Concordia 1, 26100, Cremona, CR, Italy
| |
Collapse
|
23
|
Donnarumma R, Ghidini M, Toselli G, Prandini N, Franceschetto A, Guidi G, Costi T. 335. Uncertainty in quantification of cumulative activity in bone metastasis dosimetry with 223Ra. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
24
|
Shitara K, Tabernero J, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Ganea D, Yalçın Ş, Fujitani K, Beretta G, Winkler R, Doi T, Ilson D. Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy432.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
Arkenau HT, Tabernero J, Shitara K, Dvorkin M, Mansoor W, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Ganea D, Yalçın Ş, Beretta G, Winkler R, Makris L, Doi T, Ilson D. TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy424.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
26
|
Ratti M, Valeri N, Hahne J, Lampis A, Ghidini M, Tomasello G, Tanzi G, Toppo L, Pizzo C, Donida B, Senti C, Salati M, Trombatore M, Fassan M, Passalacqua R. Correlation between clinic-pathological features, MSI, PD-L1 and survival in resectable gastric cancer: Looking for prognostic biomarkers. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
27
|
Donida B, Tomasello G, Ghidini M, Toppo L, Sabadini G, Pergola L, Buffoli F, Ungari M, Passalacqua R. Epidemiological, clinical and pathological characteristics of gastric neoplasms. The experience of the first population-based specialized gastric cancer registry in Italy. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
28
|
Tabernero J, Shitara K, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Ganea D, Yalçın Ş, Fujitani K, Beretta G, Winkler R, Makris L, Doi T, Ilson D. Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy208.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
|
29
|
Pietrantonio F, Miceli R, Rimassa L, Lonardi S, Aprile G, Mennitto A, Marmorino F, Bozzarelli S, Antonuzzo L, Tamburini E, Morano F, Rossini D, Battaglin F, Baretti M, Berenato R, Formica V, Mosconi S, Petrelli F, Ghidini M, Loupakis F, Spada D, Cinieri S, Beretta G, Falcone A, de Braud F, Cremolini C. Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram. Ann Oncol 2017; 28:555-561. [PMID: 27864220 DOI: 10.1093/annonc/mdw627] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background Regorafenib and TAS-102 have recently demonstrated statistically significant survival gains in patients with refractory metastatic colorectal cancer (mCRC). Life expectancy ≥12 weeks was an inclusion criterion in registrative trials, and the identification of proper clinical selection tools for the daily use of these drugs in heavily pre-treated patients is needed to improve the cost-benefit ratio. We aimed at building a nomogram able to predict death probability within 12 weeks from the date of assessment of refractory mCRC. Patients and methods Four hundred eleven refractory mCRC patients with ECOG performance status (PS) ≤2 receiving regorafenib, TAS-102 or other treatments were used as developing set. Putative prognostic variables were selected using a random forest model and included in a binary logistic model from which the nomogram was developed. The nomogram was externally validated and its performance was evaluated by examining calibration (how close predictions were to the actual outcome) and discriminative ability (Harrell C index) both on developing (internal validation) and validating (external validation) sets. Results Four variables were selected and included in the nomogram: PS (P < 0.0001), primary tumor resection (P = 0.027), LDH value (P = 0.0001) and peritoneal involvement (P = 0.081). In the developing set, the nomogram discriminative ability was high (C = 0.778), and was confirmed in the validating set (C = 0.778), where the overall outcome was better as a consequence of the enrichment in patients receiving regorafenib or TAS-102 (46% versus 34%; P < 0.0001). Conclusions Our nomogram may be a useful tool to predict the probability of death within 12 weeks in patients with refractory mCRC. Based on four easy-to-collect variables, the 'Colon Life' nomogram and free app for smartphones may improve mCRC patients' selection for later-line therapies and assist researchers for the enrollment in clinical trials in this setting.
Collapse
Affiliation(s)
- F Pietrantonio
- Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy
| | - R Miceli
- Trial Office and Biomedical Statistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - L Rimassa
- Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan
| | - S Lonardi
- Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova
| | - G Aprile
- Department of Oncology, University and General Hospital, Udine
| | - A Mennitto
- Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy
| | - F Marmorino
- Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa
| | - S Bozzarelli
- Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan
| | - L Antonuzzo
- S.C. Oncologia Medica 1, Azienda Ospedaliero Universitaria Careggi, Firenze.,Department of Medical Biotechnologies, University of Siena, Siena
| | - E Tamburini
- Medical Oncology Unit, Rimini Hospital, Rimini
| | - F Morano
- Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy
| | - D Rossini
- Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa
| | - F Battaglin
- Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova
| | - M Baretti
- Medical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan
| | - R Berenato
- Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy
| | - V Formica
- Medical Oncology Unit, Policlinico Tor Vergata University Hospital, Roma
| | - S Mosconi
- Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo
| | - F Petrelli
- Department of Oncology, ASST Bergamo Ovest, Treviglio, Bergamo
| | - M Ghidini
- Division of Medicine and Medical Oncology, Azienda Istituti Ospitalieri, Cremona
| | - F Loupakis
- Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Istituto Oncologico Veneto - IRCCS, Padova
| | - D Spada
- ASL Lecce-Presidio Ospedaliero Vito Fazzi, UOC Oncologia Medica, Lecce
| | - S Cinieri
- Medical Oncology, Hospital A. Perrino, Brindisi
| | - G Beretta
- Medical Oncology Unit, Humanitas Gavazzeni, Bergamo
| | - A Falcone
- Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa
| | - F de Braud
- Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1,Milan, Italy.,Oncology and Hemato-Oncology Department, University of Milan, Italy
| | - C Cremolini
- Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa
| |
Collapse
|
30
|
Occhipinti M, Botticelli A, Onesti C, Ghidini M, Righini R, Pizzo C, Milano A, Tomasello G, Di Pietro F, Toppo L, Ratti M, Passalacqua R, Marchetti P, Mazzuca F. Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx425.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Ghidini M, Donida B, Lomiento D, Ratti M, Pizzo C, Aldighieri F, Toppo L, Ranieri V, Senti C, Tanzi G, Martinotti M, Passalacqua R, Tomasello G, Rovatti M. Prognostic factors associated with survival and recurrence in resectable gastroesophageal cancer: retrospective analysis of 338 patients operated at the Hospital of Cremona in ten years' time. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx425.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Tomasello G, Petrelli F, Ghidini M, Pezzica E, Passalacqua R, Steccanella F, Turati L, Sgroi G, Barni S. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies. Eur J Surg Oncol 2017; 43:1607-1616. [DOI: 10.1016/j.ejso.2017.03.001] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 03/02/2017] [Accepted: 03/07/2017] [Indexed: 01/13/2023] Open
|
33
|
Ghidini M, Cascione L, Lampis A, Pandolfo R, Carotenuto P, Trevisani F, Hahne J, Zito D, Guzzardo V, Zerbi A, Torzilli G, Roncalli M, Rimassa L, Santoro A, Fassan M, Valeri N, Braconi C. Prognostic value of the immune-related transcriptome in biliary tract cancers. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw371.86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
34
|
Toppo L, Tomasello G, Ghidini M, Caminiti C, Maglietta G, Lazzarelli S, Liguigli W, Rovatti M, Ranieri V, Tanzi G, Buffoli F, Martinotti M, Passalacqua R. Efficacy and safety of dose-dense taxotere cisplatin fluorouracil regimen (mTCF-dd) in a large cohort of patients (pts) with metastatic or locally advanced non-squamous gastroesophageal cancer (GEC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw371.25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Yan W, Phillips LC, Barbone M, Hämäläinen SJ, Lombardo A, Ghidini M, Moya X, Maccherozzi F, van Dijken S, Dhesi SS, Ferrari AC, Mathur ND. Long Spin Diffusion Length in Few-Layer Graphene Flakes. Phys Rev Lett 2016; 117:147201. [PMID: 27740785 DOI: 10.1103/physrevlett.117.147201] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Indexed: 06/06/2023]
Abstract
We report a spin valve with a few-layer graphene flake bridging highly spin-polarized La_{0.67}Sr_{0.33}MnO_{3} electrodes, whose surfaces are kept clean during lithographic definition. Sharp magnetic switching is verified using photoemission electron microscopy with x-ray magnetic circular dichroism contrast. A naturally occurring high interfacial resistance ∼12 MΩ facilitates spin injection, and a large resistive switching (0.8 MΩ at 10 K) implies a 70-130 μm spin diffusion length that exceeds previous values obtained with sharp-switching electrodes.
Collapse
Affiliation(s)
- W Yan
- Department of Materials Science, University of Cambridge, Cambridge CB3 0FS, United Kingdom
| | - L C Phillips
- Department of Materials Science, University of Cambridge, Cambridge CB3 0FS, United Kingdom
| | - M Barbone
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, United Kingdom
| | - S J Hämäläinen
- NanoSpin, Department of Applied Physics, Aalto University School of Science, P.O. Box 15100, FI-00076 Aalto, Finland
| | - A Lombardo
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, United Kingdom
| | - M Ghidini
- Department of Materials Science, University of Cambridge, Cambridge CB3 0FS, United Kingdom
- DiFeST, University of Parma, viale G.P. Usberti 7/A, 43124 Parma, Italy
| | - X Moya
- Department of Materials Science, University of Cambridge, Cambridge CB3 0FS, United Kingdom
| | - F Maccherozzi
- Diamond Light Source, Chilton, Didcot, Oxfordshire OX11 0DE, United Kingdom
| | - S van Dijken
- NanoSpin, Department of Applied Physics, Aalto University School of Science, P.O. Box 15100, FI-00076 Aalto, Finland
| | - S S Dhesi
- Diamond Light Source, Chilton, Didcot, Oxfordshire OX11 0DE, United Kingdom
| | - A C Ferrari
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, United Kingdom
| | - N D Mathur
- Department of Materials Science, University of Cambridge, Cambridge CB3 0FS, United Kingdom
| |
Collapse
|
36
|
Toppo L, Tomasello G, Ghidini M, Liguigli W, Lazzarelli S, Caminiti C, Maglietta G, Passalacqua R. Modified dose-dense taxotere cisplatin fluorouracil regimen (mTCF-dd) in a large cohort of patients (pts) with metastatic or locally advanced non-squamous gastroesophageal cancer (GEC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw333.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
37
|
Trevisani F, Cascione L, Ghidini M, Lampis A, Fassan M, Hanhe J, Dell'Antonia G, Rigotti P, Larcher A, Capitanio U, Benigni F, Briganti A, Bertini R, Salonia A, Montorsi F, Valeri N. 228 Predictive molecular biomarkers of renal clear cell carcinoma. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/s1569-9056(16)60230-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
38
|
Ghidini M, Trevisani F, Fassan M, Cascione L, Hahne J, Lampis A, Cheong I, Scarpa A, Vicentini C, Zerbi A, Torzilli G, Roncalli M, Rimassa L, Valeri N, Santoro A, Braconi C. Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs). Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Gonçalves R, Martins P, Moya X, Ghidini M, Sencadas V, Botelho G, Mathur ND, Lanceros-Mendez S. Magnetoelectric CoFe2O4/polyvinylidene fluoride electrospun nanofibres. Nanoscale 2015; 7:8058-8061. [PMID: 25871851 DOI: 10.1039/c5nr00453e] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Magnetoelectric 0-1 composites comprising CoFe2O4 (CFO) nanoparticles in a polyvinylidene fluoride (PVDF) polymer-fibre matrix have been prepared by electrospinning. The average diameter of the electrospun composite fibres is ∼325 nm, independent of the nanoparticle content, and the amount of the crystalline polar β phase is strongly enhanced when compared to pure PVDF polymer fibres. The piezoelectric response of these electroactive nanofibres is modified by an applied magnetic field, thus evidencing the magnetoelectric character of the CFO/PVDF 0-1 composites.
Collapse
Affiliation(s)
- R Gonçalves
- Centro/Departamento de Física, Universidade do Minho, 4710-057, Braga, Portugal.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Berardi R, Caramanti M, Arvat E, Mastroianni C, Agustoni F, Tiseo M, Vincenzi B, Buosi R, Chiari R, Camerini A, Galeassi A, Ghidini M, De Marino V, Ferrari D, Doni L, Fumagalli D, Portalone L, Schinzari G, Tucci M, Cascinu S. Syndrome of Inappropriate Anti-Diuretic Hormone Secretion (Siadh) in Cancer Patients (Pts): Results of the First Multicenter Italian Survey. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu356.63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
41
|
Raglio A, van der Kooi T, Galbiati G, Averara F, Ortega AS, Cucchi E, Ghidini M, Spotti L, Mirabile C, Grigis A, Cesa S, Casati M, Farina C, Lorini L, Chiappa L, Zingg W. P004: Implementing an extensive central venous catheter bundle in the Ospedale Papa Giovanni XXIII (formerly Ospedali riuniti) of Bergamo, Italy: experiences and impact. Antimicrob Resist Infect Control 2013. [PMCID: PMC3688514 DOI: 10.1186/2047-2994-2-s1-p4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
42
|
Ghidini M, Pellicelli R, Prieto J, Moya X, Soussi J, Briscoe J, Dunn S, Mathur N. Non-volatile electrically-driven repeatable magnetization reversal with no applied magnetic field. Nat Commun 2013; 4:1453. [DOI: 10.1038/ncomms2398] [Citation(s) in RCA: 102] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2012] [Accepted: 12/17/2012] [Indexed: 11/09/2022] Open
|
43
|
Moya X, Hueso LE, Maccherozzi F, Tovstolytkin AI, Podyalovskii DI, Ducati C, Phillips LC, Ghidini M, Hovorka O, Berger A, Vickers ME, Defay E, Dhesi SS, Mathur ND. Giant and reversible extrinsic magnetocaloric effects in La0.7Ca0.3MnO3 films due to strain. Nat Mater 2013; 12:52-58. [PMID: 23104152 DOI: 10.1038/nmat3463] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2012] [Accepted: 09/18/2012] [Indexed: 06/01/2023]
Abstract
Large thermal changes driven by a magnetic field have been proposed for environmentally friendly energy-efficient refrigeration, but only a few materials that suffer hysteresis show these giant magnetocaloric effects. Here we create giant and reversible extrinsic magnetocaloric effects in epitaxial films of the ferromagnetic manganite La(0.7)Ca(0.3)MnO(3) using strain-mediated feedback from BaTiO(3) substrates near a first-order structural phase transition. Our findings should inspire the discovery of giant magnetocaloric effects in a wide range of magnetic materials, and the parallel development of nanostructured bulk samples for practical applications.
Collapse
Affiliation(s)
- X Moya
- Department of Materials Science, University of Cambridge, Cambridge, CB2 3QZ, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Pacetti P, Giovannetti E, Reni M, Mambrini A, Ghidini M, Gleon L, Funel N, Cereda S, Peters G, Cantore M. Association between DNA repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
45
|
Cereda S, Reni M, Rognone A, Ghidini M, Rezzonico S, Passoni P, Mazza E, Belli C, Zerbi A, Villa E. 6512 A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71234-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
46
|
Cereda S, Rognone A, Ghidini M, Rezzonico S, Passoni P, Mazza E, Nicoletti R, Zerbi A, Villa E, Reni M. A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.4614] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4614 Background: The combination of cisplatin (P), epirubicin (E), 5-fluorouracil (F) and gemcitabine (G) (PEFG regimen) yielded a progression-free survival at 6 months from treatment start (PFS6) of about 50% and a 1-year overall survival (OS) around 40% in patients with advanced pancreatic adenocarcinoma (PA). The current trial was aimed to assess whether the replacement of E with docetaxel (D) may improve PFS6. Methods: Chemo-naive patients with stage III or metastatic PA, age 18–75y, Karnofsky performance status (PS) >50 received P (30 mg/m2 day 1), G (800 mg/m2 day 1) and capecitabine (1250 mg/m2/day days 1 to 14) and were randomized to receive either D at 25–30 mg/m2 day 1 (arm A: PDXG regimen) or E at 30 mg/m2 day 1 (arm B: PEXG regimen). Cycles were repeated every 14 days for a maximum of 6 months. Tumor was assessed by CT scan every 8 weeks. The Fleming design was used to calculate the sample size on the probability of being PFS6 (primary endpoint). Assuming P0=40% and P1=60%, α .05 and β.10, the study was to enroll 52 patients per arm. The regimen had to be considered of interest with > 26 patients being PFS6. Results: Between July 2005 and September 2008, 105 patients were enrolled at a single institution, stratified by stage and randomized (53 arm A). Patients’ characteristics were (A/B): median age 61/59, PS > 70 92/88%, metastatic disease 66/65%; CA19.9 > upper limit of laboratory normal (ULN) 87/90%, median CA19.9 820/755 UI/mL. To date, 46 patients per arm are assessable for the primary endpoint: PFS6 was 58/54%. One- year OS was 41% in both arms. A partial response was observed in 61/37% of patients. Among assessable patients with basal CA19.9 value > ULN (37 per arm), a major biochemical response (reduction >89%) was observed in 46/35% and a minor biochemical response (reduction between 50 and 89%) in 43/35% of patients. Main per cycle G3–4 toxicity was: neutropenia 4/13%, thrombocytopenia 3/2%, anemia 4/3%, fatigue 6/4%. Conclusions: PEXG yielded similar results when compared to prior series treated by PEFG, suggesting that capecitabine may replace F. The inclusion of D instead of E seems to be promising. The present trial confirms the relevant impact on outcome of advanced PA of four-drug regimens. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- S. Cereda
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - A. Rognone
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - M. Ghidini
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - S. Rezzonico
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - P. Passoni
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - E. Mazza
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - R. Nicoletti
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - A. Zerbi
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - E. Villa
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| | - M. Reni
- San Raffaele Scientific Institute, Milan, Italy; S. Raffaele Scientific Institute, Milan, Italy
| |
Collapse
|
47
|
Piovella F, Siragusa S, Carbone S, Samaden A, Vicentini L, Beltrametti C, Ghidini M, Passera R, Taborelli P, Ascari E. Compression ultrasound in the early diagnosis of deep vein thrombosis in hip surgery: An interim analysis. Thromb Res 1992. [DOI: 10.1016/0049-3848(92)90758-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|